• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Arthritis Center

Show Search
Hide Search
  • Disease Information
    • Rheumatoid Arthritis
    • Psoriatic Arthritis
    • Ankylosing Spondylitis
    • Osteoarthritis
    • Gout
    • Osteoporosis
  • Patient Corner
    • Drug Information Sheets
    • Managing Your Arthritis
    • RheumTV – Patient Education Video Library
  • Our Research
    • Patient-Centered Outcomes Research
    • Current Research Studies
    • The Camille Julia Morgan Arthritis Research and Education Fund
  • About Us
    • Appointment Information
    • Contact Us
    • Our Faculty
    • Our Staff
    • Rheumatology Specialty Centers
  • Donate
Home / Ask the Expert / Humira and Sjogren’s Syndrome

Humira and Sjogren’s Syndrome

May 18, 2011 By Clifton Bingham, III, MD

Question

I have just started Humira for R.A. I also have Sjorgrens syndrome. Is it likely that the Humira will also help my Sjogren’s?

Answer

Sjogren’s syndrome is a common problem in patients with rheumatoid arthritis and can also occur in people without RA.  In this condition patients complain of dryness in the eyes and in the mouth and other areas.  These symtoms can be very severe.  The condition is caused by autoimunne mediated inflammation and fibrosis of the salivary glands and tear producing glands. Treatment of Sjogren’s is initially symptomatic using artificial tears, sometimes immunomodulatory eye drops such as Restasis, and plugs to increase the quantity of tears, as well as careful dental hygiene and increased fluid intake.  There are some medications that increase the flow of saliva and tears but these medications may cause frequent bowel movements and sweating in some people.  The response of Sjogren’s symptoms in RA to DMARDS is variable.  While in some patients, the symptoms improve with RA treatment, others do not.  It is not easily possible to predict which patients will or will not respond.  There are some clinical studies underway with immunomodulatory medications specifically for Sjogren’s syndrome as well.  

Clifton Bingham, III, MD

Professor of Medicine
Director - Johns Hopkins Arthritis Center

Primary Sidebar

Ask The Expert Topics

  • Alternative Therapies
  • Ankylosing Spondylitis
  • Associated With Other Illnesses
  • Bursitis and Tendinitis
  • Corticosteroids
  • Diet and Exercise
  • Disease Modifying Antirheumatic Drugs (DMARDs)
  • Enteropathic Arthritis
  • Fibromyalgia
  • General Arthritis
  • Gout, Pseudogout, Other
  • Infectious Arthritis
  • Myositis
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Osteoarthritis
  • Osteonecrosis
  • Osteoporosis
  • Polymyalgia Rheumatica
  • Psoriatic Arthritis
  • Reactive Arthritis
  • Regional Pain: Back and Neck
  • Rehabilitation
  • Rheumatoid Arthritis
  • Surgical Therapy
  • Systemic Lupus Erythematosus (SLE)
  • Systemic Sclerosis
  • Vasculitis
RheumTV Logo

Rheum.TV is an informational platform created to educate patients living with a rheumatic disease. With over 100 disease education videos produced by the team at Johns Hopkins Rheumatology.

Visit Rheum.TV

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Sjögren’s Syndrome Center
  • Johns Hopkins Vasculitis Center

Connect With Us

  • Facebook
  • Twitter
  • YouTube

Johns Hopkins Medicine

© 2023 Johns Hopkins Arthritis Center
Patient Privacy